Thorsten Sieß
Chief Tech/Sci/R&D Officer at ABIOMED, INC.
Profile
Presently, Thorsten Sieß is Chief Technology Officer & Vice President at ABIOMED, Inc. and Co-Managing Director at ABIOMED Europe GmbH (a subsidiary of ABIOMED, Inc.). He is also on the board of Arterica, Inc. Dr. Sieß received a doctorate and a graduate degree from RWTH Aachen University.
Thorsten Sieß active positions
Companies | Position | Start |
---|---|---|
ABIOMED, INC. | Chief Tech/Sci/R&D Officer | 2004-12-31 |
ABIOMED Europe GmbH
ABIOMED Europe GmbH Medical SpecialtiesHealth Technology ABIOMED Europe GmbH manufactures and markets micro blood pumps. These systems have been designed to provide a temporary solution while the patient is waiting for heart surgery or a heart transplant (bridge to operation or bridge to transplant). It is also used to stabilize the patient until a decision can be made regarding long-term therapy such as a long-term cardiovascular support system or an artificial heart. The company was founded in 1998 and is headquartered in Aachen, Germany. | Chief Executive Officer | - |
Arterica, Inc.
Arterica, Inc. Miscellaneous Commercial ServicesCommercial Services Arterica, Inc. operates as a biotechnology company. The company is headquartered in Santa Rosa, CA. | Director/Board Member | - |
Former positions of Thorsten Sieß
Companies | Position | End |
---|---|---|
Impella Cardiosystems AG
Impella Cardiosystems AG Medical SpecialtiesHealth Technology Impella Cardiosystems AG develops, manufactures, and markets minimally invasive cardiovascular support systems. The company is based in Aachen, Germany. The German company was founded by Thorsten Sieß. | Founder | - |
Training of Thorsten Sieß
RWTH Aachen University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
ABIOMED Europe GmbH
ABIOMED Europe GmbH Medical SpecialtiesHealth Technology ABIOMED Europe GmbH manufactures and markets micro blood pumps. These systems have been designed to provide a temporary solution while the patient is waiting for heart surgery or a heart transplant (bridge to operation or bridge to transplant). It is also used to stabilize the patient until a decision can be made regarding long-term therapy such as a long-term cardiovascular support system or an artificial heart. The company was founded in 1998 and is headquartered in Aachen, Germany. | Health Technology |
ABIOMED, Inc.
ABIOMED, Inc. Medical SpecialtiesHealth Technology ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA. | Health Technology |
Arterica, Inc.
Arterica, Inc. Miscellaneous Commercial ServicesCommercial Services Arterica, Inc. operates as a biotechnology company. The company is headquartered in Santa Rosa, CA. | Commercial Services |
Impella Cardiosystems AG
Impella Cardiosystems AG Medical SpecialtiesHealth Technology Impella Cardiosystems AG develops, manufactures, and markets minimally invasive cardiovascular support systems. The company is based in Aachen, Germany. The German company was founded by Thorsten Sieß. | Health Technology |
- Stock Market
- Insiders
- Thorsten Sieß